National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 76632 [2013-30012]
Download as PDF
76632
Federal Register / Vol. 78, No. 243 / Wednesday, December 18, 2013 / Notices
TABLE 1—ESTIMATED ANNUALIZED BURDEN HOURS FOR VANGUARD (PILOT) STUDY RESPONDENTS, STUDY VISITS
THROUGH 60 MONTHS OF AGE OF THE CHILD—Continued
Data collection activity
Estimated
number of
respondents
Type of respondent
Child-Focused Physical Measures—Anthropometry, Blood
Pressure, Vision Screening,
Lung Function, & Motor Skills
(6M, 12M, 24M, 36M, 48M,
60M).
Estimated
number of
responses per
respondent
Average
burden per
response
(in hrs)
Estimated total
annual burden
hours
Child .................................................
1,217
2
9/60
365
Primary Caregiver ............................
Primary Caregiver ............................
935
1,085
13
13
41/60
8/60
8,375
1,775
Primary Caregiver ............................
Primary Caregiver ............................
Primary Caregiver ............................
Primary Caregiver ............................
Child .................................................
Primary Caregiver ............................
Biological Mother, Biological Father
Primary Caregiver ............................
Primary Caregiver ............................
Primary Caregiver ............................
Child .................................................
562
1,046
1,286
1,711
1,711
1,364
1,364
1,380
1,431
1,332
1,332
1
1
1
1
1
1
1
1
1
1
1
40/60
26/60
50/60
61/60
22/60
32/60
15/60
89/60
23/60
46/60
22/60
375
453
1,072
1,740
627
728
341
2,047\
549
1,021
488
Primary Caregiver ............................
Primary Caregiver ............................
200
67
2
2
17/60
7/60
113
16
Primary Caregiver ............................
200
3
43/60
430
Total Vanguard (Pilot) Study
..........................................................
........................
........................
........................
48,567
Total Formative Research ..
..........................................................
........................
........................
........................
2,835
Environmental Sample Collection—Vacuum Bag Dust, Indoor and Outdoor Visual Observations, & Dust Wipes
(12M, 36M, 48M, 60M).
18-Month Interview ....................
24-Month Interview ....................
30-Month Interview ....................
36-Month Interview ....................
42-Month Interview ....................
48-Month Interview ....................
54-Month Interview ....................
60-Month Interview ....................
Subsample Studies:
Noise (36M, 60M) ......................
Bioelectrical Impedance Analysis (BIA) (48M, 60M).
Physical Activity (Accelerometer)
(36M, 48M, 60M).
Dated: December 6, 2013.
Sarah L. Glavin,
Deputy Director, Office of Science Policy,
Analysis, and Communications, Eunice
Kennedy Shriver National Institute of Child
Health and Human Development, National
Institutes of Health.
[FR Doc. 2013–30091 Filed 12–17–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ehiers on DSK2VPTVN1PROD with NOTICES
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Mar<15>2010
15:27 Dec 17, 2013
Jkt 232001
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Low-Dose CT
Imaging (UO1).
Date: February 26, 2014.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, DEM
II, Suite 951, 6707 Democracy Boulevard,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
6707 Democracy Boulevard, Suite 959,
Bethesda, MD 20892, 301–451–3398, hayesj@
mail.nih.gov.
Dated: December 12, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–30012 Filed 12–17–13; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the National
Diabetes and Digestive and Kidney
Diseases Advisory Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
E:\FR\FM\18DEN1.SGM
18DEN1
Agencies
[Federal Register Volume 78, Number 243 (Wednesday, December 18, 2013)]
[Notices]
[Page 76632]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-30012]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; Low-Dose CT Imaging (UO1).
Date: February 26, 2014.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, DEM II, Suite 951, 6707
Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: John K. Hayes, Ph.D., Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering, 6707
Democracy Boulevard, Suite 959, Bethesda, MD 20892, 301-451-3398,
hayesj@mail.nih.gov.
Dated: December 12, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-30012 Filed 12-17-13; 8:45 am]
BILLING CODE 4140-01-P